Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-CDA Polyclonal Antibody

Catalog #:   PHE00201 Specific References (46) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P32320
Overview

Catalog No.

PHE00201

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human CDA (Ala2-Gln146).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

Cytidine deaminase,CDD,Cytidine aminohydrolase,CDA

Purification

Purified by antigen affinity column.

Accession

P32320

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with CDA antibody (PHE00201) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 18 kDa
    Observed MW: 18 kDa
References

A case-cohort longitudinal study for the analysis of microbial associations and viruses on the risk of celiac disease (MAVRiC)., PMID:40492061

Long Covid Symptom Clusters, Correlates and Predictors in a Highly Vaccinated Australian Population in 2023., PMID:40342248

Non-Invasive Monitoring and Differentiation of Aging Mice Treated with Goat Whey Powder by an Electronic Nose Coupled with Chemometric Methods., PMID:40096321

Enterovirus VP1 protein and HLA class I hyperexpression in pancreatic islet cells of organ donors with type 1 diabetes., PMID:40090995

Joint analysis of the nPOD-Virus Group data: the association of enterovirus with type 1 diabetes is supported by multiple markers of infection in pancreas tissue., PMID:40090994

A conformational fingerprint for amyloidogenic light chains., PMID:40028903

Impact of differences between interim and post-interim analysis populations on outcomes of a group sequential trial: Example of the MOVe-OUT study., PMID:40025641

Predictors of early disability accumulation in newly diagnosed multiple sclerosis: clinical, imaging and cerebrospinal fluid measures., PMID:39961655

Therapeutic drug monitoring and immunogenetic factors associated with the use of adalimumab in Crohn's disease patients., PMID:39959979

Eastern cottontails (Sylvilagus floridanus) as hosts for ticks infected with Borrelia burgdorferi, Anaplasma phagocytophilum, and Powassan virus in Virginia, USA., PMID:39945387

Efficacy, safety and cost-effectiveness of obinutuzumab in patients with follicular lymphoma: a rapid review., PMID:39830356

Infliximab monitoring in Crohn's disease: a neural network approach for evaluating disease activity and immunogenicity., PMID:39664232

Hairy cell leukemia (HCL) and HCL-like disorders: present, emergent treatment options and future directions., PMID:39535173

Detection of host cell microprotein impurities in antibody drug products., PMID:39366928

Study of Number of Germinal Centers of Vermiform Appendix in Bangladeshi People of Different Age and Sex., PMID:39351749

M2e nanovaccines supplemented with recombinant hemagglutinin protect chickens against heterologous HPAI H5N1 challenge., PMID:39237609

The potential of mesenchymal stem cell coexpressing cytosine deaminase and secretory IL18-FC chimeric cytokine in suppressing glioblastoma recurrence., PMID:39236459

A whole-cell platform for discovering synthetic cell adhesion molecules in bacteria., PMID:39095377

Immunologic Predictors of Vaccine Responsiveness in Patients With Lymphoma and Chronic Lymphocytic Leukemia., PMID:39052709

A quadrivalent recombinant influenza Hemagglutinin vaccine induced strong protective immune responses in animal models., PMID:38834431

Prediction of progression to type 1 diabetes with dynamic biomarkers and risk scores., PMID:38797187

Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry., PMID:38761203

Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma., PMID:38709066

Impact of SARS-CoV-2 spike stability and RBD exposure on antigenicity and immunogenicity., PMID:38459086

Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma., PMID:38448430

Protein and lipid expansion microscopy with trypsin and tyramide signal amplification for 3D imaging., PMID:38081848

Celiac Disease on the Bed-Side: Embedding Case Finding and Screening in Hospitalized Children., PMID:38068757

Associations of dietary patterns between age 9 and 24 months with risk of celiac disease autoimmunity and celiac disease among children at increased risk., PMID:38044022

Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study., PMID:37783133

BNT162b2 mRNA COVID-19 Vaccine Effectiveness in Patients with Coeliac Disease Autoimmunity: Real-World Data from Mass Vaccination Campaign., PMID:37766374

TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cells., PMID:37533642

Prognostic value of spinal cord lesion measures in early relapsing-remitting multiple sclerosis., PMID:37495267

Clinical relevance of molecular aspects in extranodal marginal zone lymphoma: a critical appraisal., PMID:37389189

Efficacy of Early Optimization of Infliximab Guided by Therapeutic Drug Monitoring during Induction-A Prospective Trial., PMID:37371853

Supramolecular Filament Hydrogel as a Universal Immunomodulator Carrier for Immunotherapy Combinations., PMID:37212741

Lymph Node Follicle-Targeting STING Agonist Nanoshells Enable Single-Shot M2e Vaccination for Broad and Durable Influenza Protection., PMID:37092580

Treat-to-target in the management of moderate-to-severe atopic dermatitis in adults: A Canadian perspective., PMID:37074241

Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial., PMID:37052965

Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD., PMID:36809847

Long-term follow-up of patients with hairy cell leukemia in the south of Iran., PMID:36709461

Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease Patients., PMID:36700064

In-depth immunophenotyping reveals significant alteration of lymphocytes in buffalo with brucellosis., PMID:36602043

IFN-α/β Signaling Is Required for CDG-Mediated CTL Generation and B Lymphocyte Activation., PMID:36559314

Reply to Ito., PMID:36533701

Engineered anti-EGFRvIII targeted exosomes induce apoptosis in glioblastoma multiforme., PMID:36440540

Systematic review: early feeding practices and the risk of coeliac disease. A 2022 update and revision., PMID:36411726

Datasheet

Document Download

Anti-CDA Polyclonal Antibody.pdf

 

$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-CDA Polyclonal Antibody [PHE00201]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only